Related Experiment Video
Updated: Jun 24, 2026
06:09
Development of a Preclinical Inhalation Model to Test Vaporized Cannabis Distillates
Published on: May 30, 2025
Marijuana and chronic obstructive lung disease: a population-based study
Wan C Tan1, Christine Lo, Aimee Jong
1iCapture Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital and the University of British Columbia, Vancouver, Canada. wtan@mrl.ubc.ca
Summary
Concurrent tobacco and marijuana smoking significantly elevates risks for respiratory symptoms and COPD. Smoking only marijuana showed no increased risk, but combined use synergistically harms respiratory health.
Area of Science:
- Pulmonology
- Epidemiology
- Public Health
Background:
- Investigating the respiratory health impacts of combined tobacco and marijuana use is crucial.
- Understanding the independent and synergistic effects of these substances on COPD prevalence is essential.
Purpose of the Study:
- To determine the combined and independent effects of tobacco and marijuana smoking on respiratory symptoms.
- To assess the impact of concurrent smoking on the prevalence of chronic obstructive pulmonary disease (COPD).
Main Methods:
- A random sample of 878 adults aged 40+ in Vancouver, Canada, was surveyed.
- Spirometric testing was conducted pre- and post-salbutamol administration.
- Associations between smoking habits and COPD were analyzed.
Main Results:
- Tobacco smoking alone increased respiratory symptoms and COPD risk.
- Concurrent tobacco and marijuana use synergistically increased risks for respiratory symptoms and COPD, particularly with higher lifetime marijuana consumption.
- Smoking only marijuana was not linked to increased respiratory symptoms or COPD.
Conclusions:
- Combined tobacco and marijuana smoking presents a synergistic risk for respiratory symptoms and COPD.
- Public health strategies should address the compounded respiratory risks associated with dual substance use.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation